Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Access to Medical Treatment Act

This article was originally published in The Tan Sheet

Executive Summary

Access to Medical Treatment Act: Is expected to be introduced the week of June 26 by Rep. Peter DeFazio (D-Ore.). The bill, which was introduced last year by DeFazio as HR 4696 and by Sen. Tom Daschle (D-S.D.) as S 2140, broadens access to unapproved medical treatments provided they are not harmful. The 1995 version has been amended to address concerns raised by the dietary supplement industry that language in the bill could allow a supplement to be deemed "dangerous" if given in conjunction with a harmful therapy ("The Tan Sheet" March 20, p. 14). The bill is understood to contain a provision stating that the act will not conflict with the Dietary Supplement Health & Education Act. DeFazio is considering a hearing on the issue...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083958

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel